يعرض 1 - 10 نتائج من 15 نتيجة بحث عن '"NASH non-alcoholic steatohepatitis"', وقت الاستعلام: 1.40s تنقيح النتائج
  1. 1

    المصدر: JHEP Reports, Vol 3, Iss 6, Pp 100370-(2021)
    Grønkjær, L L & Lauridsen, M M 2021, ' Quality of life and unmet needs in patients with chronic liver disease : A mixed-method systematic review ', JHEP Reports, vol. 3, no. 6, 100370 . https://doi.org/10.1016/j.jhepr.2021.100370Test
    JHEP Reports

    وصف الملف: application/pdf

  2. 2

    المصدر: JHEP Reports
    JHEP Reports, Vol 4, Iss 2, Pp 100412-(2022)

  3. 3

    المساهمون: Gastroenterology & Hepatology

    المصدر: JHEP Reports, Vol 3, Iss 5, Pp 100350-(2021)
    JHEP Reports
    JHEP Reports, 3(5):100350. Elsevier

    وصف الملف: application/pdf

  4. 4

    المصدر: JHEP Reports
    JHEP Reports, Vol 3, Iss 6, Pp 100381-(2021)

  5. 5

    المصدر: JHEP Reports, Vol 3, Iss 4, Pp 100293-(2021)
    JHEP Reports

  6. 6

    المصدر: JHEP Reports, Vol 3, Iss 4, Pp 100299-(2021)
    JHEP Reports
    Suppli, M P, Bagger, J I, Lelouvier, B, Broha, A, Demant, M, Kønig, M J, Strandberg, C, Lund, A, Vilsbøll, T & Knop, F K 2021, ' Hepatic microbiome in healthy lean and obese humans ', JHEP Reports, vol. 3, no. 4, 100299 . https://doi.org/10.1016/j.jhepr.2021.100299Test

    وصف الملف: application/pdf

  7. 7

    المصدر: JHEP Reports
    JHEP Reports, Vol 3, Iss 5, Pp 100351-(2021)

  8. 8

    المصدر: JHEP Reports, Vol 3, Iss 3, Pp 100256-(2021)
    JHEP Reports

  9. 9

    المصدر: JHEP Reports, Vol 3, Iss 2, Pp 100217-(2021)
    JHEP Reports

  10. 10

    المصدر: JHEP Reports

    مصطلحات موضوعية: MPS type VII, MPSVII, S/MAR, scaffold matrix attachment regions, PB, piggyBac, gene addition, GalNAc, N-acetyl-D-galactosamine, UCD, urea cycle disorders, Genetic enhancement, medicine.medical_treatment, efficacy, MMA, methylmalonic acidemia, Review, Liver transplantation, medicine.disease_cause, MPS, mucopolysaccharidosis, immune response, IDS, iduronate 2-sulfatase, lncRNA, long non-coding RNA, gene silencing, GSD1a, glycogen storage disorder 1a, AAV, adeno-associated virus, ASOs, antisense oligonucleotides, Genome editing, AHP, acute hepatic porphyrias, HT, hereditary tyrosinemia, IMLD, inherited metabolic liver diseases, PFIC3, progressive familial cholestasis type 3, Immunology and Allergy, NHPs, non-human primates, CRISPR/Cas9, CRISPR associated protein 9, GO, glycolate oxidase, HemA/B, haemophilia A/B, Adeno-associated virus, HDR, homology-directed repair, Transcription activator-like effector nuclease, LNP, Lipid nanoparticles, siRNA, small-interfering RNA, MPR, metabolic pathway reprograming, LDH, lactate dehydrogenase, PH1, Primary hyperoxaluria type 1, gene editing, SRT, substrate reduction therapy, Gastroenterology, Ad, adenovirus, AAT, α1-antitrypsin, PA, propionic acidemia, dCas9, dead Cas9, ERT, enzyme replacement therapy, HDAd, helper-dependent adenovirus, CRISPR, clustered regularly interspaced short palindromic repeats, SB, Sleeping Beauty, LDLR, low-density lipoprotein receptor, MPS type I, MPSI, hepatocytes, OTC, ornithine transcarbamylase, APCs, antigen-presenting cells, DSBs, double-strand breaks, viral vectors, LV, lentivirus, AIP, acute intermittent porphyria, NASH, non-alcoholic steatohepatitis, GT, gene therapy, PKU, phenylketonuria, Computational biology, Gene delivery, Biology, FH, familial hypercholesterolemia, Viral vector, ITR, inverted terminal repetition, ZFN, zinc finger nucleases, GUSB, β-glucuronidase, Internal Medicine, medicine, OLT, orthotopic liver transplantation, Gene silencing, miRNAs, microRNAs, ASGPR, asialoglycoprotein receptor, ALAS1, aminolevulic synthase 1, TALEN, transcription activator-like effector nucleases, CBS, cystathionine β-synthase, PEG, polyethylene glycol, PEI, polyethyleneimine, TTR, transthyretin, Hepatology, IDUA, α-L-iduronidase, toxicity, ASGCT, American Society of Gene and Cell Therapy, CN, Crigel-Najjar, STK25, serine/threonine protein kinase 25, VLDLR, very-low-density lipoprotein receptor, WD, Wilson’s disease, FSP27, fat-specific protein 27, NHEJ, non-homologous end joining, Non-viral vectors, LTR, long terminal repeat, apoB/E, apolipoprotein B/E, RV, retrovirus, PCSK9, proprotein convertase subtilisin/kexin type 9